A. Dimitrios Colevas
Professor
Medicine - Oncology
Stanford University
United States of America
Biography
Dr. A. Dimitrios Colevas is a professor of medicine (oncology) and, by courtesy, of otolaryngology - head and neck surgery at the stanford university medical center.His clinical focusus are in Cancer:Head and Neck Cancer, Oncology (Cancer), developmental therapeutics, investigational new drugs, Adverse event( toxicity) evaluation and reporting, Thyroid Cancer, combined chemotherapy and radiation treatment and Medical Oncology.
Research Interest
Dabrafenib in Treating Patients With BRAF Mutated Ameloblastoma, Capecitabine in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Skin, A 3rd/4th Line Placebo-controlled Trial of Sorafenib in Patients With Predominantly Non Squamous Non-Small Cell Lung Cancer (NSCLC).
Publications
-
Ransohoff A, Wood D, Solomon Henry A, Divi V, Colevas A (2016) Third party assessment of resection margin status in head and neck cancer. Oral oncology 57: 27-31
-
Beswick DM, Holsinger FC, Kaplan MJ, Fischbein NJ, Hara W, et al. (2016) Design and rationale of a prospective, multi-institutional registry for patients with sinonasal malignancy. Laryngoscope 126: 1977-1980
-
Rosen LS, LoRusso P, Ma WW, Goldman JW, Weise A, (2016) A first-in-human phase I study to evaluate the MEK1/2 inhibitor, cobimetinib, administered daily in patients with advanced solid tumors. Investigational new drugs 34: 604-613
